18F-Fluorothymidine PET for Functional Response Assessment Following Radiation Therapy for Extramedullary Hematopoiesis

Clin Nucl Med. 2021 Sep 1;46(9):e454-e457. doi: 10.1097/RLU.0000000000003566.

Abstract

As a marker of cellular proliferation, 18F-fluorothymidine (FLT) PET can detect the distribution of proliferating hematopoiesis and has an emerging role in the investigation of hematopoietic disorders. These images demonstrate the novel utility of 18F-FLT PET for imaging sites of extramedullary hematopoiesis (EMH) in a patient with Chuvash-type polycythemia and suggest a role for 18F-FLT PET in response assessment following radiotherapy. Further, the discordant response observed in the irradiated marrow and sites of EMH is a unique discovery, possibly suggesting the influence of the microenvironment favoring more rapid recovery of proliferative function within EMH sites.

MeSH terms

  • Bone Marrow / diagnostic imaging
  • Dideoxynucleosides
  • Hematopoiesis, Extramedullary*
  • Humans
  • Positron-Emission Tomography

Substances

  • Dideoxynucleosides